Israeli Researchers Develop Blood Test for Early Breast Cancer Detection
Summarized from All Israel News by baba
Israeli researchers have developed a blood test that detects early breast cancer with 95% accuracy and assesses recurrence risk. The test uses epigenetic markers in the bloodstream and demonstrated effectiveness regardless of breast density. It also identified recurrence risk in patients considered low-risk by conventional methods. The findings, published in Nature, could lead to new treatments targeting epigenetic changes in cancer cells.
The story in 5 lines · by baba
- Israeli researchers developed a blood test detecting early breast cancer with 95% accuracy.
- The test also assesses recurrence risk, identifying high-risk patients, including those considered low-risk.
- The method uses epigenetic markers found in nucleosomes released into the bloodstream.
- Published in Nature, the test works regardless of breast density, unlike mammograms.
- Researchers are exploring treatments to target epigenetic changes that make cancer cells aggressive.
All Israel News publishes in English. The key points are summarized above. Read All Israel News’s full report from the link at the top of the page.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 1Right 1
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
